Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut–Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers
Antonio Gil‐Gómez, Paola Brescia, María Rescigno, et al.
Seminars in Liver Disease (2021) Vol. 41, Iss. 02, pp. 191-205
Open Access | Times Cited: 18

Showing 18 citing articles:

The gut vascular barrier: a new player in the gut–liver–brain axis
Paola Brescia, María Rescigno
Trends in Molecular Medicine (2021) Vol. 27, Iss. 9, pp. 844-855
Closed Access | Times Cited: 106
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk
Keungmo Yang, Myeong Jun Song
Nutrients (2023) Vol. 15, Iss. 18, pp. 3970-3970
Open Access | Times Cited: 22
Microbiota–gut–brain axis: interplay between microbiota, barrier function and lymphatic system
Miaomiao Zhuang, Xun Zhang, Jun Cai
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids
Jie Jian, Mei‐Tong Nie, Baoyu Xiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 31
Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention
Lucrezia Irene Maria Campagnoli, Nicoletta Marchesi, Mariapia Vairetti, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2827-2827
Open Access | Times Cited: 25
Role of the afferent lymph as an immunological conduit to analyze tissue antigenic and inflammatory load
Padma P. Nanaware, Zohaib N. Khan, Cristina C. Clement, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114311-114311
Open Access | Times Cited: 5
Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
Xiaoli Pan, Yanqiao Zhang
Chinese Medical Journal (2022) Vol. 135, Iss. 10, pp. 1172-1181
Open Access | Times Cited: 21
Unravelling the gut-liver axis: The role of gut microbiota-mitochondria interactions in the pathogenesis and management of metabolic-associated fatty liver disease (MAFLD)
Binzhi Zhang, Xia Luo, Lei Song, et al.
Journal of Holistic Integrative Pharmacy (2025) Vol. 6, Iss. 1, pp. 23-40
Open Access
Supplementation of Lactobacillus plantarum ATCC14917 mitigates non-alcoholic fatty liver disease in high-fat-diet-fed rats
Xingjian Wen, Hejing Liu, Luo Xiao-ling, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Therapeutic potential of rifaximin in liver diseases
Wanting Yang, Gaoyue Guo, Chao Sun
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117283-117283
Open Access | Times Cited: 2
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies
Ángela Rojas, María del Rosario García-Lozano, Antonio Gil‐Gómez, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 10, Iss. 2, pp. 356-362
Open Access | Times Cited: 12
Interventions for non-alcoholic liver disease: a gut microbial metabolites perspective
Jin Guo, Chunxia Shi, Qingqi Zhang, et al.
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 8
Unveiling the role of gut dysbiosis in non-alcoholic fatty liver disease
Pranali Jadhav, Asha Thomas, Rabindra K. Nanda, et al.
European Journal of Gastroenterology & Hepatology (2023) Vol. 35, Iss. 12, pp. 1324-1333
Closed Access | Times Cited: 4
Looking for a new name for Non-alcoholic fatty liver disease in Spanish: Esteatosis Hepática Metabólica (EHmet)
Manuel Romero‐Gómez, Javier Ampuero
Revista Española de Enfermedades Digestivas (2021)
Open Access | Times Cited: 8
Vascular and lymphatic regulation of gastrointestinal function and disease risk
Vincenza Cifarelli, Vivek S. Peche, Nada A. Abumrad
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2022) Vol. 1867, Iss. 11, pp. 159207-159207
Open Access | Times Cited: 4
Daphnetin Alleviates Nash by Modulating Lipid Metabolism, Bile Acids and Gut Microbiota in Mcd Diet Mice
Xiaolei Miao, Ping Luo, Yiye Zhao, et al.
(2024)
Closed Access
The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment
Gautam Maddineni, Sri J. Obulareddy, Ruchir Paladiya, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 8, pp. 4714-4731
Open Access
Altered intestinal flora in patients with primary immune thrombocytopenia
Honghui Wang, Hui Bi, Muran Yang, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top